Replies to post #212567 on Cytodyn Inc (CYDY)

[justdafactss]

Clinical holds on HIV and COVID and failed clinical trials---

CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19 Program

The partial clinical hold on the HIV program impacts patients currently enrolled in extension trials. These patients will be transitioned to other available therapeutics and no clinical studies can be initiated or resumed until the partial clinical hold is resolved.

Under the full clinical hold on the COVID-19 program, no new clinical studies may be initiated until the clinical hold is resolved.
https://finance.yahoo.com/news/cytodyn-announces-partial-clinical-hold-210000247.html

With the conclusion of both the CD10 and CD12 clinical trials, it has become clear that the data currently available do not support the clinical benefit of leronlimab for the treatment of COVID-19.
https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab?Mon,%2017%20May%202021%2014:59:28%20EDT

You're not going to find it because it's older than dirt

But but but but for example, GSK still has PRs posted older than dirt---

https://www.gsk.com/en-gb/media/press-releases/?ps=100#all

[3X Charm]

“blah...how come Nader has not sold a single share”…..Complete BS. Nader sold 4.2 million shares right after he directed Amarex to file the short HIV BLA.